BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 1804896)

  • 41. Serological monitoring of the response to chemotherapy in leprosy patients.
    Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidrug therapy--the pathway for global leprosy elimination.
    al-Qubati Y; al-Kubati AS
    Indian J Lepr; 2000; 72(4):477-90. PubMed ID: 11212482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-dose treatment for paucibacillary leprosy; clinical problems and management.
    Pai VV; Bulchand HO; Revankar CR; Ganapati R
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):310-2. PubMed ID: 10575414
    [No Abstract]   [Full Text] [Related]  

  • 45. Chemotherapy of leprosy for control programmes.
    World Health Organ Tech Rep Ser; 1982; 675():1-33. PubMed ID: 6806990
    [No Abstract]   [Full Text] [Related]  

  • 46. Genital involvement and type I reaction in childhood leprosy.
    Gupta R; Singal A; Pandhi D
    Lepr Rev; 2005 Sep; 76(3):253-7. PubMed ID: 16248212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. "Flu" syndrome on monthly rifampin dose; first case reported from Yemen.
    al-Samie AR; al-Qubati Y
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):574-6. PubMed ID: 8642225
    [No Abstract]   [Full Text] [Related]  

  • 48. Recent trends in chemotherapy of leprosy.
    Parikh DA; Maniar JK; Parikh AC; Ganapati R
    J Assoc Physicians India; 1985 Sep; 33(9):593-5. PubMed ID: 3912375
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapy of the mycobacterial diseases--leprosy and tuberculosis.
    Krenzien HN
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):223-32. PubMed ID: 6762341
    [No Abstract]   [Full Text] [Related]  

  • 50. Does dapsone resistance really matter in the MDT era?
    Ji B
    Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):54-5. PubMed ID: 11480322
    [No Abstract]   [Full Text] [Related]  

  • 51. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 52. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A; Nadkarni NJ; Kini MS; Mehta VR
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Supervised administration of multidrug therapy in leprosy colonies through volunteers--a bacteriological assessment.
    Ganapati R; Naik SS; Revankar CR; Vartak RB; Desai AP; Panvalkar NA; Deshpande SS
    Indian J Lepr; 1986; 58(1):86-90. PubMed ID: 3528338
    [No Abstract]   [Full Text] [Related]  

  • 54. Coexistence of borderline tuberculoid Hansen's disease with tuberculosis verrucosa cutis in a child--a rare case.
    Ravindra K; Sugareddy ; Ramachander T
    Indian J Lepr; 2010; 82(2):91-3. PubMed ID: 21434512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of sulphone resistant leprosy--a review of sixty one cases.
    Seshadri PS; Ravi NT
    Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123
    [No Abstract]   [Full Text] [Related]  

  • 56. Relapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
    Shetty VP; Antia NH
    Lepr Rev; 1997 Jun; 68(2):162-6. PubMed ID: 9217356
    [No Abstract]   [Full Text] [Related]  

  • 57. Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
    Sehgal VN; Kumar S; Jain S; Bhattacharya SN
    J Dermatol; 1998 Jan; 25(1):63-5. PubMed ID: 9519615
    [No Abstract]   [Full Text] [Related]  

  • 58. WHO Expert Committee on Leprosy.
    World Health Organ Tech Rep Ser; 1988; 768():1-51. PubMed ID: 3140498
    [No Abstract]   [Full Text] [Related]  

  • 59. [The problem of resistance in the treatment of Mycobacterium infections: new experimental results and combinations for the treatment of tuberculosis and leprosy].
    Seydel JK; Schaper KJ
    Pharm Unserer Zeit; 1995 Nov; 24(6):313-23. PubMed ID: 8592712
    [No Abstract]   [Full Text] [Related]  

  • 60. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.